|
|||||
|
|
Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma |
|
| Authors: | Luke J Nelson Kyleen E Castro Binzhi Xu Junyi Li Nguyen B Dinh Jordan M Thompson Jordan Woytash Kevin R Kipp Olga V Razorenova |
| Affiliation: | aDepartment of Molecular Biology and Biochemistry, University of California, Irvine, California, USA;bBioniz Therapeutics, Irvine, California, USA |
| Abstract: | |
| Keywords: | |